Seguir
David Vivas-Consuelo
David Vivas-Consuelo
Health Economics. Universitat Poliècnica de València.
Dirección de correo verificada de upv.es - Página principal
Título
Citado por
Citado por
Año
Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries
A Ament, R Baltussen, G Duru, C Rigaud-Bully, D De Graeve, Å Örtqvist, ...
Clinical Infectious Diseases 31 (2), 444-450, 2000
1902000
Is Health Related Quality of Life (HRQoL) a valid indicator for health systems evaluation?
M Romero, D Vivas-Consuelo, N Alvis-Guzman
Springerplus 2, 1-7, 2013
1382013
A model to measure the efficiency of hospital performance
M Caballer-Tarazona, I Moya-Clemente, D Vivas-Consuelo, ...
Mathematical and computer modelling 52 (7-8), 1095-1102, 2010
1152010
COVID-19, fake news, and vaccines: should regulation be implemented?
JE Marco-Franco, P Pita-Barros, D Vivas-Orts, S González-de-Julián, ...
International journal of environmental research and public health 18 (2), 744, 2021
952021
Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data
C Sancho-Mestre, D Vivas-Consuelo, L Alvis-Estrada, M Romero, ...
BMC Health Services Research 16, 1-8, 2016
94*2016
Estudo Delphi: atores sociais e tendências do sistema de saúde brasileiro
SF Piola, SM Vianna, D Vivas-Consuelo
Cadernos de Saúde Pública 18, S181-S190, 2002
502002
Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups
D Vivas-Consuelo, R Usó-Talamantes, JL Trillo-Mata, ...
Health Policy 116 (2-3), 188-195, 2014
402014
Application of Lean Healthcare methodology in a urology department of a tertiary hospital as a tool for improving efficiency
F Boronat, A Budia, E Broseta, JL Ruiz-Cerdá, D Vivas-Consuelo
Actas Urológicas Españolas (English Edition) 42 (1), 42-48, 2018
342018
Explaining primary healthcare pharmacy expenditure using classification of medications for chronic conditions
D Vivas, N Guadalajara, I Barrachina, JL Trillo, R Usó, E de-la-Poza
Health Policy 103 (1), 9-15, 2011
312011
Tendências do sistema de saúde brasileiro: estudo Delphi
SFC Piola, DVC Consuelo, SMC Vianna
Instituto de Pesquisa Econômica Aplicada (Ipea), 2001
272001
Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool
D Vivas-Consuelo, R Usó-Talamantes, N Guadalajara-Olmeda, ...
BMC health services research 14 (1), 1-11, 2014
262014
Atención a mujeres inmigrantes en un programa de mediación intercultural en salud
M Alcaraz Quevedo, JJ Paredes-Carbonell, C Sancho Mestre, ...
Revista espanola de salud publica 88 (2), 301-310, 2014
25*2014
Innovazione e formazione nel settore socio-sanitario
UV CABALLER, M La Rosa
Milano: Franco Angeli, 1995
161995
Measurement of health-related quality by multimorbidity groups in primary health care
M Millá-Perseguer, N Guadalajara-Olmeda, D Vivas-Consuelo, ...
Health and quality of life outcomes 17 (1), 1-10, 2019
142019
The cost-effectiveness of Haemophilus influenzae type b vaccine for children under 2 years of age in Colombia
F De La Hoz Restrepo
Revista Panamericana de Salud Publica= Pan American Journal of Public Health …, 2006
142006
Relación costo-efectividad de la vacuna contra Haemophilus influenzae tipo b en niños menores de dos años de edad en Colombia
NA Guzmán, F De La Hoz Restrepo, DV Consuelo
Revista Panamericana de Salud Pública 20 (4), 248-255, 2006
14*2006
COVID-19 healthcare planning: Predicting mortality and the role of the herd immunity barrier in the general population
JE Marco-Franco, N Guadalajara-Olmeda, S González-de Julián, ...
Sustainability 12 (13), 5228, 2020
132020
Organisations in the social economy in health care and social services: an overview
V Caballer, ES Ruano, D Vivas, I Vidal
Delivering Welfare: repositioning non-profit and co-operative action in …, 1994
131994
Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports
JA Román Ivorra, N Fernández-Llanio-Comella, A San-Martín-Álvarez, ...
Clinical rheumatology 38, 1857-1864, 2019
122019
Cost-effectiveness analysis of the human recombinant epidermal growth factor in the management of patients with diabetic foot ulcers
M Romero Prada, C Roa, P Alfonso, G Acero, L Huérfano, ...
Diabetic foot & ankle 9 (1), 1480249, 2018
122018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20